Biomarkers for precision medicine in bladder cancer Takahiro KojimaKoji KawaiHiroyuki Nishiyama Invited Review Article 29 November 2016 Pages: 207 - 213
Recent progress and perspectives on prostate cancer biomarkers Shingo HatakeyamaTohru YoneyamaChikara Ohyama Invited Review Article Open access 11 October 2016 Pages: 214 - 221
The sesquiterpene α-bisabolol in the adipocyte−cancer desmoplastic crosstalk: does it have an action on epithelial−mesenchymal transition mechanisms? Salvatore ChirumboloGeir Bjørklund Review Article 09 December 2016 Pages: 222 - 228
The effect of consolidation chemotherapy after concurrent chemoradiotherapy on the survival of patients with locally advanced non-small cell lung cancer: a meta-analysis Xinshuai WangXuezhen DingShegan Gao Review Article 22 December 2016 Pages: 229 - 236
Status of oncologic specialties: global survey of physicians treating cancer Takefumi KomiyaChristine B. MackayPrabhakar Chalise Original Article 27 October 2016 Pages: 237 - 243
Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution Taichi YoshidaDaiki TaguchiHiroyuki Shibata Original Article 10 November 2016 Pages: 244 - 249
Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control Akifumi MiyakawaYuta ShibamotoTatsuo Hirai Original Article 08 November 2016 Pages: 250 - 256
Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer Jun Sakakibara-KonishiYasuyuki IkezawaMasaharu Nishimura Original Article 05 November 2016 Pages: 257 - 268
Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population Yoshitaka NishikawaMasashi KanaiManabu Muto Original Article 10 November 2016 Pages: 269 - 273
Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001 Norihito OkumuraMakoto SonobeHiroshi Date Original Article 05 December 2016 Pages: 274 - 282
Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis Mei FengJing ZhuFuqiang Wen Original Article 18 December 2016 Pages: 283 - 290
A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer Ying LiuYing LiaoShilong Sun Original Article 24 October 2016 Pages: 291 - 296
Clinical outcomes of stage IV colorectal cancer after R0 resection: a multi-institutional retrospective analysis Harunobu SatoKoutarou MaedaJapanese Study Group for Postoperative Follow-up of Colorectal Cancer Original Article 06 October 2016 Pages: 297 - 306
A population-specific correlation between ADIPOQ rs2241766 and rs 1501299 and colorectal cancer risk: a meta-analysis for debate Lin YeGuobin WangJie Bai Original Article 04 October 2016 Pages: 307 - 315
Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers Satoshi NagayamaSuguru HasegawaShinji Uemoto Original Article 17 October 2016 Pages: 316 - 323
Risk scores as useful predictors of perioperative complications in patients with rectal cancer who received radical surgery Hiroshi MiyakitaSotaro SadahiroToshiyuki Suzuki Original Article Open access 25 October 2016 Pages: 324 - 331
Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems Abdelfattah M. AttallahMohamed M. OmranIbrahim El-Dosoky Original Article 18 November 2016 Pages: 332 - 339
Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review Kaoru OkugawaHiroaki KobayashiKiyoko Kato Original Article 01 November 2016 Pages: 340 - 346
Hyaluronic acid binding protein 1 overexpression is an indicator for disease-free survival in cervical cancer Ming ZhangNa LiChunying Liu Original Article 30 December 2016 Pages: 347 - 352
Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study Naoto KamiyaHiroyoshi SuzukiTomohiko Ichikawa Original Article 15 October 2016 Pages: 353 - 358
Biphasic decline in renal function after radical cystectomy with urinary diversion Katsuhiro MakinoTohru NakagawaYukio Homma Original Article 17 October 2016 Pages: 359 - 365
Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma Ken FukushiTakuma NaritaChikara Ohyama Original Article 08 December 2016 Pages: 366 - 372
A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer Takuya ShimizuguchiKeiji NiheiKatsuyuki Karasawa Original Article 24 October 2016 Pages: 373 - 379
Multidisciplinary evaluation at baseline and during treatment improves the rate of compliance and efficacy of deferasirox in elderly myelodysplastic patients Lisette Del CorsoLucia BialeEleonora Arboscello Original Article 22 October 2016 Pages: 380 - 386
Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study Hiroki HoriTooru KudohFor the Japan Association of Childhood Leukemia Study Original Article 17 November 2016 Pages: 387 - 396
Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study Masanori MoriYongli JiSteven Ades Original Article 15 September 2016 Pages: 397 - 404
Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan Kazuo TamuraKeisuke AibaThe CINV Study Group of Japan Original Article 01 December 2016 Pages: 405 - 412